Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Apr 19, 2017 4:39pm
317 Views
Post# 26139397

RE:I asked Fred about PLI knowing anything about Boehriner NR

RE:I asked Fred about PLI knowing anything about Boehriner NRThanks Closely, I guess when I read the Boehringer NR re: Nintandab I realized just how difiicult it is for Prometic re. testing, competition, takeovers etc. "the jungle".  Prometic is still a very small fish and could easily get swallowed up. I find it a little discouraging but hope that Pierre & Company have a good handle on everything.  Boehringer says their test will take 52 weeks.  That is a long time... 
Bullboard Posts